![Jia Kui Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 6 M $ au 31/05/2026
Jia Kui Li worked at Xuanzhu Biopharmaceutical Co., Ltd. from 2018 to 2026 and was Executive Director in 2026.
Dr. Li earned a doctorate from Long Island University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/06/2026 | 3 020 800 ( 0,58% ) | 6 M $ | 31/05/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| XUANZHU BIOPHARMACEUTICAL CO., LTD. | Directeur Général | 05/01/2026 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Long Island University
 Long Island University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xuanzhu Biopharmaceutical Co., Ltd.
 Xuanzhu Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development, production and commercialization of drugs for digestive disease, oncology and non-alcoholic steatohepatitis | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
